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Introduction: Heart failure is a disease in which there is a mismatch between blood supply 
and demand o f  the organs, in which case the heart undergoes molecular changes, also known as 
cardiac remodeling.
Cardiac remodeling is the restructuring and reshaping o f the heart that underlies heart failure 
progression.
The traditional concepts o f  cellular remodeling in the failing heart are characteristic alterations 
in cell size, shape, and the ability to perform contractile work.
Aim: Studying the immediate and long-term manifestations o f  the cardiac remodeling aspects 
in the body.
Materials and methods : A wide variety o f  experiments, researches and hours were put into 
understanding chronic heart failure and its molecular changes, which we were supported by, as well 
as the facts provided by a couple o f  cardiologists we seeked.
Discussions and results: Heart failure is a disease in which there is a mismatch between 
blood supply and demand o f  the organs, in which case the heart undergoes molecular changes. In 
the United States, it is estimated that heart failure develops in 465,000 people each year. Heart 
failure occurs in both men and women and is associated with a high morbidity and mortality rate in 
both sexes and in all races. The traditional concepts o f  cellular remodeling in the failing heart are 
characteristic alterations in cell size, shape, and the ability to perform contractile work. Cellular 
changes in heart failure include myocyte hypertrophy, abnormalities in calcium homeostasis, 
excitation-contraction coupling, cross-bridge cycling, and changes in the cytoskeletal architecture.
Myocardial remodeling denotes acquired pathological states o f  the heart resulting in 
rearrangement o f  normally existing structures and generally concerns the two components o f  the 
cardiovascular system, the myocardium and the vessels, the structure o f both can be altered by 
unfavorable conditions caused by several noxious stimuli that impose increased biomechanical 
stress to the cardiomyocytes. In response to an increased workload, individual cardiomyocytes react 
by adaptive hypertrophic growth, they increase in cell size, volume and mass, or undergo apoptosis, 
respectively. As a result, there is organ enlargement, cardiac dilation and increased sphericity. 
Although salutary at the beginning by reducing wall tension, hypertrophy eventually becomes a 
maladaptive process, leading to chronic heart failure and cardiac mortality. Dilation is followed by 
increased ventricular wall stress resulting in decreased coronary blood flow, impaired pump 
function and diminished cardiac output. Moreover, interstitial fibrosis is observed, further hindering 
systolic and diastolic cardiac function.
Conclusions:
1. Heart failure is compensated through pathogenetic mechanisms, which maintain cardiac 
performance.
2. Compensatory mechanisms cause molecular remodeling, that compromise systolic and 
diastolic cardiac function.
3. Finally, the logistical challenges o f  studying human cardiac gene expression emphasize the 
need for newer noninvasive approaches to study m olecular aspects o f  cardiac remodeling in human 
subjects. Many strategies are evolving to do Ihis, including novel circulating biomarkcrs, studies o f  
inherited gene variation in hypertrophic signaling pathways, and molecular imaging. These 
techniques will undoubtedly help us test the clinical relevance o f  mechanisms o f  cardiac remodeling 
discovered in animal models and thereby identify novel therapeutic targets for human heart failure.
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